Smart Capital Traders
  • Politics
  • Investing
  • Latest News
  • Stocks

Smart Capital Traders

  • Politics
  • Investing
  • Latest News
  • Stocks
Latest News

Iran’s jailed Nobel laureate Narges Mohammadi allowed to leave prison for 21 days after surgery

by admin December 4, 2024
December 4, 2024
Iran’s jailed Nobel laureate Narges Mohammadi allowed to leave prison for 21 days after surgery

Iranian authorities have allowed Narges Mohammadi, the country’s most prominent human rights activist and 2023 Nobel Peace Prize winner, to leave prison for 21 days to recover from surgery for suspected cancer, a decision her family has criticized as “too little, too late.”

An Iranian prosecutor on Tuesday suspended Mohammadi’s prison term for three weeks – instead of the three months requested by her family and lawyers – to allow her to recover from an operation she had in November to remove part of a bone in her lower right leg, where doctors had discovered a lesion suspected of being cancerous.

“After over a decade of imprisonment, Narges required specialized medical care in a safe, sanitary environment – a basic human right,” the foundation said. “As doctors have emphasized, a minimum of three months’ recovery is crucial for her healing.”

The Narges Foundation, which is run by her family, criticized the ruling as giving her insufficient time to recover. It had previously requested she be released for at least three months.

Mohammadi has spent most of the past two decades as an inmate of Tehran’s Evin prison – notorious for housing critics of the Iranian regime.

She is serving multiple sentences totaling more than 30 years, having been accused of acting against national security and spreading propaganda against the state.

Supporters say she’s a political prisoner who was detained for trying to advance women’s rights and democracy in the country.

In 2023, she was awarded the Nobel Peace Prize for her “fight against the oppression of women in Iran and her fight to promote human rights and freedom for all.”

In November, her family accused the Iranian regime of trying to bring about her “slow death” by depriving her of the surgery needed to confirm her cancer diagnosis.

Her family and lawyer had warned that any delay in treating her could prove fatal and had called for her to be granted “medical furlough” to cover both the suspected cancer treatment and a range of other health conditions she is grappling with.

According to her lawyer, a recent MRI revealed the progression of arthritis and disc disease while doctors have also called for a further angiography on one of her heart arteries after she suffered a heart attack in 2021.

However, her foundation noted that Tuesday’s ruling was a suspension of her sentence, rather than a furlough.

“Unlike a ‘medical furlough,’ which would have allowed the recovery period to count toward her prison term, this suspension means that upon her return, she will be required to serve an additional 30 days,” the foundation said.

“Weeks of enduring excruciating pain in prison, despite tireless advocacy from fellow inmates, human rights organizations, and international figures, highlights the persistent disregard for Narges Mohammadi’s basic human rights and the inhumane treatment she endures,” the foundation added.

While in prison, Mohammadi has continued to campaign for human rights causes, lobbying for the rights of Iranian women and calling for a peaceful resolution to the war in Gaza.

Former US Secretary of State Hillary Clinton is among the high-profile figures to have recently called for her release.

This post appeared first on cnn.com

previous post
Russia will use ‘even stronger military means’ if Western pressure continues, warns deputy foreign minister
next post
North Korea, Russia and China watch on as crisis unfolds in key US ally South Korea

related articles

Israeli strike kills 11 people, including head of...

January 2, 2025

Why Trump’s strikes on Iran will leave North...

June 26, 2025

Pope gives Easter blessing in highest-profile appearance yet...

April 20, 2025

Pro-Russia Romanian presidential candidate questioned by prosecutors, his...

February 26, 2025

Desperate to get its illegally detained civilians out...

June 8, 2025

More than a third of this country’s population...

June 27, 2025

Seven hotel guests hospitalized after drinking cocktails at...

December 16, 2024

Mexico prepares to appear before US Supreme Court...

February 27, 2025

Pope Francis to be hospitalized for bronchitis treatment...

February 14, 2025

Pyrotechnics blamed as fire rips though North Macedonia...

March 16, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Most Popular

    • 1

      Bold Ventures Announces Final Closing of Non-Brokered Private Placement and Insider Subscriptions

      October 19, 2024
    • 2

      Retraction of Forecast Financial Information Plus Announcement on New Metallurgical Testwork Results

      October 15, 2024
    • 3

      As North Korea, Iran and China support Russia’s war, is a ‘new axis’ emerging?

      October 25, 2024
    • 4

      Lode Gold Launches Exploration Program at One of the Largest Land Packages in New Brunswick

      October 19, 2024
    • 5

      Emyria and UWA in Partnership to Commercialise Novel Serotonin-Releasing Agents for Mental Health and Neurology

      October 31, 2024

    Categories

    • Investing (2,599)
    • Latest News (2,300)
    • Politics (3,132)
    • Stocks (990)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: smartcapitaltraders.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 smartcapitaltraders.com | All Rights Reserved